NEW YORK (GenomeWeb News) – Sigma-Aldrich laid off 130 employees during the third quarter as part of a restructuring plan, the St. Louis company disclosed in its Form 10-Q recently.

In the document filed with the US Securities and Exchange Commission, the company said that it committed to a restructuring plan during the third quarter to reduce its global headcount and further reduce its fixed cost structure. The cost of the restructuring is $5 million, of which $4 million was recorded in the quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.